35 results about "Trichoderma citrinoviride" patented technology

The invention discloses a microbial inoculum for preventing and curing fungal diseases of plants; the active ingredients contain Trichoderma longibrachiatum and Trichoderma citrinoviride. The microbial inoculum of the invention is used to carry out control efficiency experiments and the results show that the control efficiency of liquid microbial inoculum to cucumber blight is up to 54.8% and thecontrol efficiency to green pepper phytophthora disease is up to 67.9%; the control efficiency of solid microbial inoculum to cucumber blight is up to 45.12% and the yield of cucumber is increased by11.06% so that the effect for preventing diseases and increasing yield is obvious; the control efficiency of solid microbial inoculum to green pepper phytophthora disease is up to 61.90% and the average plant height of the green pepper in experimental group is increased by 8.92% compared with that of the green pepper in control group and the yield of green pepper is increased by 37.19% so that the microbial inoculum of the invention is shown to have obvious effect for preventing increases, promoting the growth and increasing the yield.

The present invention relates to producing micropropagules from Trichoderma citrinoviride EGE-K-130 mold strain isolated from resources of our country and whose strain is molecularly identified, as a bio-control agent by means of an economical production process.

The invention relates to a lactone derivative derived from trichoderma citrinoviride and application thereof. The compound contains a molecular skeleton of hetero-oxygen atom pentacyclic lactone, and two methyls on the ring are located at the same side of the molecule. Verified by experiments, the lactone derivative has excellent anti-tumor activity. Besides, the lactone derivative can be applied to preparation of a cell proliferation inhibition drug or an anti-tumor drug and used for anti-tumor research.

The invention relates to application of penicillium enol E1 deriving from trichoderma citrinoviride in preparation of an anti-lymphoma drug. The compound is structurally characterized by containing a molecular skeleton of pentacyclic amide and a carbonyl group connected with a deca-carbon saturated fat long chain, wherein a methyl group is connected with N, and a molecule comprises two hydroxyl groups. It is verified through experiments that the alkaloid compound has good inhibitory activity on lymphoma and can be used for preparing a drug for inhibiting lymphoma cell proliferation or the anti-lymphoma drug and used in anti-tumor research.

The invention discloses an application of penilloenol E1 derived from Trichoderma citrinoviride in lung cancer. The structure of the compound is characterized in that the structure contains a pentacycloamide molecule skeleton, and a carbonyl group connected C10 saturated fat long chain, N is connected with a methyl group, and two hydroxyl groups exist in the molecule. Experiments confirm that the above alkaloid compound has good inhibition activity to lung cancer cells, can be used for preparing lung cancer cell proliferation inhibition medicines or anti-lung cancer medicines, and is used for antitumor researches.

The invention relates to penem enol E1 derived from trichoderma citrinoviride and application in preparation of an anti-oral epidermoid carcinoma drug. The compound is structurally characterized by containing a molecular skeleton of pentacyclic amide, a carbonyl connected with a long n-decyl saturated aliphatic chain, a methyl connected to N and molecules existing in two hydroxyl groups. An experiment proves that the alkaloid compound has good oral epidermoid carcinoma inhibiting activity. The penem enol E1 can serve as a drug for inhibiting oral epidermoid carcinoma cell proliferation or the anti-oral epidermoid carcinoma drug for antitumor research.

The invention relates to application of penem alcohol E1 derived from trichoderma citrinoviride in the aspect of gastric cancer. The compound is structurally characterized in that a molecular skeleton of pentacycloamide is contained, a carbonyl is contained and connected with a decacarbon saturated fat long chain, a methyl is connected on N, and two hydroxyl groups exist in a molecule. Experiments verify that the alkaloid-type compound has high inhibition activity to gastric cancer cells. The penem alcohol E1 can be used for preparing gastric cancer cell proliferation inhibition drugs or anti-gastric-cancer drugs and can be used for antitumor study.

The invention discloses application of trichoderma citrinoviride-derived penicillium enol E1 to a liver cancer aspect. The compound has the following structure characteristics: a molecular skeleton contains one pentacyclic amide, one carbonyl is connected with one 10-carbon saturated fat long chain, N is connected with one methyl and two hydroxyl groups exist in the molecule. Experiments prove that the alkaloid compound has high inhibition activity on liver cancer cells, can be used for preparing medicines for inhibiting proliferation of the liver cancer cells or medicines for resisting liver cancer, and is applied to anti-tumor research.

The invention relates to an alkaloid compound from Trichoderma citrinoviride and an application thereof. The structure of the compound is characterized in that the compound contains a molecular skeleton of pentacyclic amide and contains an unsaturated ketone connecting a 8-carbon saturated aliphatic long-chain; a methyl group is connected at N; and there are two hydroxyl groups in the molecule. It is confirmed through experiments that the alkaloid compound has good antineoplastic activity and can be used to prepare a cell proliferation inhibitor or antineoplastic drug for antineoplastic researches.

The invention discloses a trichoderma citrinoviride strain. The trichoderma citrinoviride strain is preserved in China General Microbiological Culture Collection Center (CGMCC), and the preservation number of the trichoderma citrinoviride strain is CGMCC No. 8722. The trichoderma citrinoviride strain has the advantages that the trichoderma citrinoviride strain dissolves pathogenic fungus cell walls through the self-produced fungal cell wall degrading enzyme, the trichoderma citrinoviride strain seeps into the cells of pathogenic fungi to form a large amount of branches and sexual structures, the growth of the pathogenic fungi is inhibited, and the pathogenic fungi die; the pathogenic fungi of pepper damping-off can be efficiently inhibited by the trichoderma citrinoviride strain, pepper damping-off is reduced, and the trichoderma citrinoviride strain can replace chemical pesticides to inhibit pepper damping-off while environmental protection is achieved.

The invention provides a COD (chemical oxygen demand)-degrading fungicide agent and a preparation method thereof. The COD-degrading fungicide agent comprises compound fungicide liquid, a protective agent and a carrier, wherein the compound fungicide liquid comprises Aspergillus calidoustus liquid, trichoderma citrinoviride liquid, aspergillus niger liquid and rhizopus stolonifer liquid; the protective agent comprises skim milk powder, trehalose, calcium carbonate and glycerin. The preparation method comprises the following steps of (1) mixing the Aspergillus calidoustus liquid, the trichoderma citrinoviride liquid, the aspergillus niger liquid and the rhizopus stolonifer liquid into the compound fungicide liquid, adding the protective agent, and uniformly mixing; (2) crushing the carrier and treating by a 60 to 100-mesh sieve; (3) adding the crushed carrier into the compound fungicide liquid, uniformly mixing, pre-freezing, and drying, so as to obtain the fungicide agent. The fungicide agent has the advantages that the fungicide agent is used as a degradable microorganism, the strain is stable, the synergistic action is obvious, and the COD in sewage is favorably degraded.